OpenAI released GPT-Rosalind, a reasoning model specifically engineered for life sciences research. The tool accelerates the transition from initial hypothesis to laboratory experiment. Access remains tightly controlled during this initial phase. This specialized approach targets high-precision scientific workflows where general-purpose models often fail, providing researchers with a more reliable reasoning engine.